"Furthermore, to benchmark the tRiAD approach we also targeted the mdx mice via CRISPR based genome editing of the nonsense mutation"
A-to-I editing mechanism (non-#CRISPR)
"Through CRISPR/Cas9-mediated deletions, we demonstrate a physiological role for intragenic enhancer-mediated transcription attenuation in cell fate determination."